Biodel Reports Second Quarter Fiscal Year 2016 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Biodel Reports Second Quarter Fiscal Year 2016 Financial Results

DANBURY, CT --(Marketwired - May 09, 2016) - Biodel Inc. ( NASDAQ : BIOD ) today reported financial results for the second fiscal quarter ended March 31, 2016.

"As we continue to diligently evaluate strategic alternatives to create shareholder value, we have significantly reduced our operating cash burn and anticipate further reductions in expenses," said Gary Gemignani, Biodel's interim CEO. "On an operating basis, we expect our quarterly cash burn to be approximately $1.1 million, as communicated during our January restructuring update."

Second Quarter Financial Results

Biodel reported a net loss of $5.9 million, or $0.09 per share for the quarter ended March 31, 2016. These results compare to a net loss of $4.4 million, or $0.18 per share, for the quarter ended March 31, 2015. General and administrative expenses were $4.0 million for the quarter ended March 31, 2016, compared to $1.6 million for the quarter ended March 31, 2015. Included in these expenses were approximately $0.3 million in professional service fees incurred related to the ongoing evaluation of strategic alternatives, and severance payments of $3.0 million pursuant to the previously announced restructuring.

Biodel did not recognize any revenue during the quarter ended March 31, 2016 or 2015.

At March 31, 2016, Biodel had cash and cash equivalents of $33.4 million and 64.1 million shares of common stock outstanding.

 
Biodel Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
         
    September 30, 2015   March 31, 2016
        (unaudited)
ASSETS        
Current:        
  Cash and cash equivalents   $ 40,845     $ 33,433  
  Restricted cash     -       21  
  Prepaid and other assets     262       684  
                 
      Total current assets     41,107       34,138  
  Property and equipment, net     280       -  
  Intellectual property, net     37       35  
                 
      Total assets   $ 41,424     $ 34,173  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY                
Current:                
  Accounts payable   $ 421     $ 115  
  Accrued expenses:                
    Clinical trial expenses     1       30  
    Payroll and related     863       233  
    Accounting and legal fees     289       269  
    Restructuring     -       1,404  
    Other     234       143  
  Income taxes payable     -       16  
                 
      Total current liabilities     1,808       2,210  
                 
  Common stock warrant liability     5       3  
  Restructuring and other long term liabilities     54       965  
                 
      Total liabilities     1,867       3,178  
Commitments                
  Stockholders' equity:                
  Convertible preferred stock, $.01 par value; 50,000,000 shares authorized; 1,909,410 and 0 issued and outstanding     19       -  
  Common stock, $.01 par value; 200,000,000 shares authorized; 62,151,202 and 64,148,271 issued and outstanding     622       641  
  Additional paid-in capital     287,212       287,733  
  Accumulated deficit     (248,296 )     (257,379 )
                 
      Total stockholders' equity     39,557       30,995  
                 
      Total liabilities and stockholders' equity   $ 41,424     $ 34,173  
                       
                       
Biodel Inc.
Condensed Consolidated Statements of Operations
(in thousands, except share and per share amounts)
(unaudited)
                 
    Three Months Ended March 31,   Six Months Ended March 31,
    2015   2016   2015   2016
Revenue   $ -     $ -     $ -     $ -  
                                 
Operating expenses:                                
  Research and development     2,917       2,091       6,324       3,685  
  General and administrative     1,611       3,989       3,444       5,621  
                                 
Total operating expenses     4,528       6,080       9,768       9,306  
Other (income):                                
  Interest and other income     (7 )     (220 )     (16 )     (237 )
  Adjustment to fair value of common stock warrant liability     (166 )     -       (712 )     (2 )
                                 
Loss before tax provision     (4,355 )     (5,860 )     (9,040 )     (9,067 )
Tax provision     1       8       3       16  
                                 
Net loss     (4,356 )     (5,868 )     (9,043 )     (9,083 )
                                 
                                 
Net loss per share - basic and diluted   $ (0.18 )   $ (0.09 )   $ (0.40 )   $ (0.15 )
                                 
Weighted average shares outstanding - basic and diluted     24,369,246       64,148,271       22,809,903       61,053,997  
                                 

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at  www.biodel.com .

Safe-Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements that address operating performance, or other events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our most recent Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission.

BIOD-G

CONTACT: Clayton Robertson The Trout Group +1 (646) 378 2964

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 89

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
Fold Health's AI: Revolutionizing Patient Care Dynamics

Updated Category News Views 85

AI's Role in Healthcare: From Insight to Action Healthcare's got a resource issue, plain and simple. It's like trying to fill a bathtub with a hole in it—clinicians are swamped, burnout is high, and patients aren't getting the attention they need. Enter Fold Health's AI operating layer, launched with the ambition to realign the equation. Not Just Another Tech Buzzword...

Continue Reading
Ave7® Pioneers AI-Driven Marketplace Evolution

Updated Category News Views 47

AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 134

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 96

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 122

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 57

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 115

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 217

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 102

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading

Top 5 Most Recently Viewed Articles

Mining Stocks: Resilience Amid Market Fluctuations and Trends

Updated Category News Views 466

Understanding the Mining Stocks' Performance In recent discussions, subscribers to the Mining Stock Journal have raised an intriguing question: Will a significant decline in the broader market be necessary for mining stocks to continue their upward trajectory? This line of thought seems to resonate with several market analysts, but it warrants a closer look. Mining stocks...

Continue Reading
Goliath Resources Unveils Ambitious 40,000-Meter Drill Campaign

Updated Category News Views 191

Exciting Times for Goliath Resources Goliath Resources is embarking on a groundbreaking journey with its largest drill campaign yet, focusing entirely on the high-grade gold discovery known as Surebet. This campaign aims to cover an impressive 40,000 meters and will utilize nine drilling rigs. The motivation for such an extensive drilling program stems from the...

Continue Reading
Who Will Dominate the Semiconductor Sector in 2024?

Updated Category News Views 137

The Competitive Landscape of Semiconductors The semiconductor industry is currently experiencing fierce competition, with three key players at the forefront: Broadcom Inc (NASDAQ: AVGO), Micron Technology Inc (NASDAQ: MU), and Marvell Technology Inc (NASDAQ: MRVL). By examining the specific strengths and hurdles each company faces, investors can gain valuable insights...

Continue Reading
Goldman Sachs' Recent Options Activity Shows Enthusiasm

Updated Category News Views 228

The Bullish Sentiment Surrounding Goldman Sachs In recent times, major financial players have shown a notable bullish sentiment towards Goldman Sachs Gr (NASDAQ: GS). Our analysis of the options market reveals intriguing insights through 37 distinctive trades surrounding this financial powerhouse. When we look deeper into the trading data, it's noteworthy that...

Continue Reading
Eramet's Strategies for Enhanced Operational Efficiency in 2025

Updated Category News Views 305

Analyzing Eramet's Strategic Direction in 2025 Eramet's commitment to operational efficiency has never been more critical than in 2025, especially after encountering significant pressures during the first half of the year. The company's recent announcements underscore an enhancement in various operational protocols, demonstrating a resilient approach towards addressing...

Continue Reading